← All ETFs
Compare ETFs
4 funds side by side
How to read this: These ETFs report returns on different bases (Price Return, Total Return), so the return figures are not directly comparable. You are comparing an accumulating and a distributing ETF. Returns are shown as total return where available, so the distributing fund is not unfairly penalised for paying dividends out as cash.
Growth of €100, side by side
Xtrackers MSCI Pacific Ex Japan UCITS ETF 1C +2.1%iShares Core MSCI Pacific ex-Japan UCITS ETF +0.3%iShares MSCI AC Far East ex-Japan UCITS ETF -6.5%
Each fund rebased to 100 at the start of the shared window — weekly closing prices, end-of-day. Past performance does not predict the future.
|
Xtrackers MSCI Pacific Ex Japan UCITS ETF 1C
Xtrackers
|
iShares Core MSCI Pacific ex-Japan UCITS ETF
iShares
|
iShares MSCI AC Far East ex-Japan UCITS ETF
iShares
|
iShares MSCI AC Far East ex-Japan UCITS ETF
iShares
|
|
|---|---|---|---|---|
| 1-yr return | +11.2% Price Return | +15.0% Total Return | +60.6% Price Return | Not stated |
| TER (yearly cost) | 0.25% | 0.20% lowest cost | 0.74% | 0.74% |
| Dividends | Reinvests dividends (accumulating) | Reinvests dividends (accumulating) | Pays you cash (distributing) | Reinvests dividends (accumulating) |
| How it’s built | Owns the shares (physical) | Owns the shares (physical) | Owns the shares (physical) | Owns the shares (physical) |
| What it holds | Stocks (equity) | Stocks (equity) | Stocks (equity) | Stocks (equity) |
| Index | MSCI Pacific ex Japan Index | MSCI Pacific | MSCI AC Far East ex-Japan Index | MSCI Ac Far East Ex-japan |
| Fund size | €0 | €3.4B | €1.8B | €1.8B |
| Home country (domicile) | LU | IE | IE | IE |
| Currency | USD | USD | USD | USD |
| Primary ticker | XPXJ | CPXJ | IDFF | IFFI |
| ISIN | LU0322252338 | IE00B52MJY50 | IE00B0M63730 | IE00BKPX3K41 |
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.